What we do
Medtech intelligence for diligence, market education, and evidence strategy.
We support targeted engagements where clinical nuance, evidence interpretation, stakeholder behavior, and commercial adoption dynamics matter.
Investor diligence
- Clinical and commercial diligence memos
- Market and care pathway maps
- Evidence-risk assessments
- KOL interview guide development
- Competitive landscape and substitution-risk analysis
Therapeutic area intelligence
- Category primers for unfamiliar clinical markets
- Stakeholder and specialty maps
- Clinical workflow and decision-driver analysis
- Conference, publication, and trial theme synthesis
- Device and company education decks
Evidence generation strategy
- Evidence roadmap development
- Endpoint and study design strategy support
- Publication and education planning
- Adoption-barrier and evidence-gap assessment
- Investor-facing evidence narrative support
KOL mapping and education
- KOL identification and segmentation
- Advisory board design
- Educational program development
- Speaker and investigator targeting support
- Stakeholder messaging frameworks
Confidential inquiry
Need decision-ready intelligence on a medtech market, company, or device?
Share the therapeutic area, company, device category, or evidence question you are evaluating. Please do not submit confidential, MNPI, or patient-identifiable information through the website.